Mass Drug Administration (MDA) in elimination of lymphatic filariasis: Assessment in Part of Eastern India

An original research

https://doi.org/10.53730/ijhs.v6nS9.12746

Authors

  • Anil Kumar Agrawal Community Medicine, Bhima Bhoi Medical College, Balangir- 767001, Odisha, India.
  • Tushar Kanti Meher Community Medicine, Bhima Bhoi Medical College, Balangir- 767001, Odisha, India.
  • Pradip Kumar Bhue Community Medicine, Bhima Bhoi Medical College, Balangir- 767001, Odisha, India.
  • Gurukrushna Mohapatra Community Medicine, IMS & SUM Hospital, Siksha O Anusandhan (Deemed to be) University, Bhubaneswar-751003, Odisha, India.
  • Manasee Panda Community Medicine, Bhima Bhoi Medical College, Balangir- 767001, Odisha, India.

Keywords:

Lymphatic Filariasis, MDA, Coverage, Compliance, Effective Supervised Coverage

Abstract

Lymphatic filariasis, a group of parasitic infections which can lead to disfigurement, disability and chronic pain. It causes social stigma which adversely affects their social and economic life. For elimination of LF, mass drugs administration is being implemented since 2004 in Odisha. A cross-sectional study was conducted in Baragarh district in the month of April 2021. Data regarding MDA was collected from 300 (200 rural and 100 urban) households (HHs) in a pre-designed, pretested questionnaire. A total of 300 households were covered in the post MDA survey of Bargarh with 1412 individuals. Of them, 1367 (96.8%) were found to be eligible. Of those who received the drugs, compliance was 94.1%. Overall effective coverage of MDA was 82%. But the difference in compliance among the three studied clusters was not found to be significant. In all the age groups only 25% of the eligible persons had consumed the drugs in front of the DD (Effective Supervised coverage). Though the coverage and compliance were found to be better, the effective supervised coverage of MDA is still low.  

Downloads

Download data is not yet available.

References

Eliminating lymphatic filariasis in Odisha, http:// end the neglect.org/2015/12/eliminating-lymphatic-filariasis-in-Odisha/ [Accessed on 20.10.2021]

Filariasis Control in India & Its Elimination, Guidelines on Elimination of Lymphatic Filariasis India. nvbdcp.gov.in/doc/guidelines-filariasis-elimination-india.pdf [Accessed on 20.10.2021]

Global Programme to Eliminate Lymphatic Filariasis progress report 2000–2009 and strategic plan 2010–2020.(WHO/HTM/NTD/PCT/2010.6). Geneva, World Health Organization, 2010. [Accessed on 20.10.2021]

National vector borne disease control programme, DGHS, MoHFW. [Accessed on 20.10.2021]

Park’s, K. Park’s Text book of Preventive and Social Medicine.24th edition. India: Bhanot; 2017 For elimination of lymphatic filariasis community should be made aware about the MDA

Bhue, P. K., Majhi, P., & Panda, M. (2021). Coverage and compliance of mass drug administration for elimination of lymphatic filariasis in a district of western Odisha, India. Journal of Evidence Based Medicine and Healthcare, 8(4), 2058-63.

Hussain, M. A., Sitha, A. K., Swain, S., Kadam, S., & Pati, S. (2014). Mass drug administration for lymphatic filariasis elimination in a coastal state of India: a study on barriers to coverage and compliance. Infectious diseases of poverty, 3(1), 1-8.

Bhatia, V., Giri, P. P., Sahoo, S. S., Preeti, P. S., & Sahu, D. P. (2018). Mass Drug Administration (MDA) for Elimination of Lymphatic Filariasis: Experiences from Nayagarh District of Odisha, India. Indian Journal of Community Health, 30(3).

Satapathy, D. M., Pradhan, S. K., Acharya, H. P., Nayak, U., Agrawal, S. K., Naik, G., & Sinha, U. (2016). Rural and Urban Differences in MDA Coverage for Filariasis in Jharsuguda District of Odisha. Int J Med Res Prof, 2(5), 70-4.

https://www.who.int/lymphatic_filariasis/eliminationprgramme/en. [Accessed on 04.10.2020]

Roy, R. N., Sarkar, A. P., Misra, R., Chakroborty, A., Mondal, T. K., & Bag, K. (2013). Coverage and awareness of and compliance with mass drug administration for elimination of lymphatic filariasis in Burdwan District, West Bengal, India. Journal of Health, Population, and Nutrition, 31(2), 171.

Ranganath, T. S., & Reddy, N. R. (2012). Elimination of lymphatic filariasis: Mass drug administration in endemic areas of (Bidar district) Karnataka-2008. Indian journal of community medicine: official publication of Indian Association of Preventive & Social Medicine, 37(4), 219.

Babu, B. V., & Mishra, S. (2008). Mass drug administration under the programme to eliminate lymphatic filariasis in Orissa, India: a mixed-methods study to identify factors associated with compliance and non-compliance. Transactions of the Royal Society of Tropical Medicine and Hygiene, 102(12), 1207-1213.

Kumar, A., Kumar, P., Nagaraj, K., Nayak, D., Ashok, L., & Ashok, K. (2009). A study on coverage and compliance of mass drug administration programme for elimination of filariasis in Udupi district, Karnataka, India. Journal of vector borne diseases, 46(3), 237.

Murthy, M. N., & Kumar, K. R. (2018). Coverage and compliance towards mass drug administration programme against lymphatic filariasis in Vijayapura (Bijapur) district, Karnataka, India. International Journal Of Community Medicine And Public Health, 5(10), 4311.

Banerjee, S., Bandyopadhyay, K., Khan, M. F., Akkilagunta, S., Selvaraj, K., Tripathy, J. P., & Deshmukh, P. (2019). Coverage of mass drug administration for elimination of lymphatic filariasis in urban Nagpur, Central India: A mixed method study. Journal of Family Medicine and Primary Care, 8(9), 3009.

Published

15-09-2022

How to Cite

Agrawal, A. K., Meher, T. K., Bhue, P. K., Mohapatra, G., & Panda, M. (2022). Mass Drug Administration (MDA) in elimination of lymphatic filariasis: Assessment in Part of Eastern India: An original research. International Journal of Health Sciences, 6(S9), 1721–1732. https://doi.org/10.53730/ijhs.v6nS9.12746

Issue

Section

Peer Review Articles